NEW YORK, May 14, 2021 /PRNewswire/ PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced the winners of
Through end-to-end automation, the company’s unique technology platform rapidly delivers reliable, reproducible, and fully auditable datasets
Arctoris Ltd
Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery.
February 24, 2021
OXFORD, UK February 10, 2021
Life Science Newswire Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its fifth anniversary on Feb. 4. Over the past five years, Arctoris has grown from a technology startup to a globally operating company delivering integrated drug discovery projects with partners on three continents from its headquarters in Oxford and its Asia-Pacific hub in Singapore. On the occasion of its fifth anniversary, Arctoris unveiled its new and expanded, next-generation robotic platform, Ulysses.
How Automation Can Augment Drug Discovery Research labiotech.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from labiotech.eu Daily Mail and Mail on Sunday newspapers.
Industry News: Arctoris celebrates 5th anniversary and launches its expanded robotic platform Ulysses
11 Feb 2021
Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its 5th anniversary on the 4th of February.
Over the past five years, Arctoris has grown from a technology startup to a globally operating company delivering integrated drug discovery projects with partners on three continents from its headquarters in Oxford and its Asia-Pacific hub in Singapore. On the occasion of its 5th anniversary, Arctoris unveiled its new and expanded, next-generation robotic platform, Ulysses.
Arctoris was founded in 2016 by Martin-Immanuel Bittner MD DPhil (CEO) and Tom Fleming MChem (COO), as the world’s first fully automated drug discovery platform. Through end-to-end automation, the company’s unique technology platform rapidly delivers reliable, reproducible, and fully auditable datasets enabling better decision-making earl
Arctoris Celebrates 5th Anniversary and Launches Its Expanded Robotic Platform Ulysses
Arctoris Ltd, an Oxford-based technology company operating a fully automated drug discovery platform, celebrated its 5th anniversary on the 4th of February. Over the past five years, Arctoris has grown from a technology startup to a globally operating company delivering integrated drug discovery projects with partners on three continents from its headquarters in Oxford and its Asia-Pacific hub in Singapore. On the occasion of its 5th anniversary, Arctoris unveiled its new and expanded, next-generation robotic platform,
Ulysses.
Ulysses is an advanced, fully automated robotic platform developed and operated by Arctoris that provides superior quality data and accelerates drug discovery. Image Credit: Arctoris Ltd